aTYR PHARMA INC SEC filings ATYR

aTYR PHARMA INC has 755 filings in SEC EDGAR's recent list, going back to Sep 23, 2005. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 26, 2026 Dec 31, 2025
10-K Annual report Mar 5, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 19, 2025 Dec 31, 2024
10-K Annual report Mar 13, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 5, 2024 Dec 31, 2023
10-K Annual report Mar 14, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K Annual report Mar 24, 2021 Dec 31, 2020
10-K Annual report Mar 26, 2020 Dec 31, 2019
10-K Annual report Mar 26, 2019 Dec 31, 2018
10-K Annual report Mar 20, 2018 Dec 31, 2017
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ATYR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1339970

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.